Epcoritamab
Epcoritamab Uses, Dosage, Side Effects, Food Interaction and all others data.
Epcoritamab is under investigation in clinical trial NCT04628494 (A Phase 3 Trial of Epcoritamab in R/R DLBCL).
| Trade Name | Epcoritamab |
| Generic | Epcoritamab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Epcoritamab
